“…Control of asthma through interventions (e.g., inhaled corticosteroid [ICS]) improved airway inflammation, respiratory symptoms, asthma exacerbations, rescue medication use, quality of life, and bronchial responsiveness, suggesting that early ICS intervention might have beneficial effects for those at risk of poor long-term asthma outcomes (17–19). In addition, the recent literature suggests that childhood asthma poses numerous health threats through asthma-associated infectious and inflammatory disease comorbidities (AIICs) (20–31). Both children and adults with asthma are at an increased risk of serious respiratory infections [e.g., pneumococcal pneumonia or invasive pneumococcal diseases (20–22), pertussis (23), and common upper respiratory infections (e.g., otitis media and strep infection) (24–26).…”